E. Daudén

10.8k total citations
267 papers, 5.4k citations indexed

About

E. Daudén is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, E. Daudén has authored 267 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 165 papers in Immunology, 95 papers in Dermatology and 53 papers in Rheumatology. Recurrent topics in E. Daudén's work include Psoriasis: Treatment and Pathogenesis (154 papers), Dermatology and Skin Diseases (63 papers) and Health Systems, Economic Evaluations, Quality of Life (32 papers). E. Daudén is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (154 papers), Dermatology and Skin Diseases (63 papers) and Health Systems, Economic Evaluations, Quality of Life (32 papers). E. Daudén collaborates with scholars based in Spain, Germany and Italy. E. Daudén's co-authors include L. Puig, Amaro García‐Diez, Francisco Abad‐Santos, J.L. Sánchez‐Carazo, J.M. Carrascosa, Teresa Cabaleiro, F. Vanaclocha, Manuel Román, Rocío Prieto‐Pérez and Silvia González‐Parra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nature Immunology and Scientific Reports.

In The Last Decade

E. Daudén

254 papers receiving 5.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
E. Daudén 3.5k 1.8k 1.2k 712 699 267 5.4k
Lotus Mallbris 3.5k 1.0× 2.1k 1.2× 1.2k 1.0× 396 0.6× 631 0.9× 96 4.8k
Andrea L. Neimann 3.8k 1.1× 1.7k 1.0× 1.3k 1.1× 424 0.6× 691 1.0× 33 5.2k
A. David Burden 3.6k 1.0× 2.5k 1.4× 686 0.6× 437 0.6× 697 1.0× 96 4.8k
C. Papavassilis 3.8k 1.1× 2.3k 1.3× 913 0.8× 492 0.7× 763 1.1× 51 4.7k
Reva Bhushan 2.7k 0.8× 2.3k 1.3× 676 0.6× 520 0.7× 447 0.6× 17 4.5k
Yves Poulin 3.9k 1.1× 4.7k 2.6× 1.0k 0.8× 942 1.3× 822 1.2× 169 7.1k
Daniel B. Shin 6.1k 1.7× 3.0k 1.6× 2.1k 1.7× 750 1.1× 1.0k 1.5× 105 8.7k
Paolo Gisondi 5.8k 1.7× 3.3k 1.8× 2.5k 2.1× 985 1.4× 975 1.4× 285 8.7k
Richard B. Warren 6.2k 1.8× 3.4k 1.9× 1.9k 1.6× 456 0.6× 1.0k 1.5× 344 8.1k
Joseph F. Merola 4.3k 1.2× 2.0k 1.1× 3.3k 2.8× 567 0.8× 789 1.1× 420 6.8k

Countries citing papers authored by E. Daudén

Since Specialization
Citations

This map shows the geographic impact of E. Daudén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Daudén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Daudén more than expected).

Fields of papers citing papers by E. Daudén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Daudén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Daudén. The network helps show where E. Daudén may publish in the future.

Co-authorship network of co-authors of E. Daudén

This figure shows the co-authorship network connecting the top 25 collaborators of E. Daudén. A scholar is included among the top collaborators of E. Daudén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Daudén. E. Daudén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Daudén, E., José María Ortiz Salvador, J. Notario, et al.. (2025). Secukinumab for Treatment of Plaque Psoriasis in Real-World Clinical Practice in Spain: A Literature Review. Journal of Clinical Medicine. 14(2). 478–478. 2 indexed citations
2.
Llamas‐Velasco, Mar, Susana Armesto, Antonio Sahuquillo‐Torralba, et al.. (2025). Genetic Polymorphisms in Psoriasis: Investigating Genetic Variations for Precise Profiling of Response to Brodalumab in Real-Life Clinical Practice. Actas Dermo-Sifiliográficas. 116(8). 824–829.
3.
Daudén, E., et al.. (2025). [Translated article] Expert Recommendations on Topical Therapy for Psoriasis from the Spanish Psoriasis Working Group (GPS). Actas Dermo-Sifiliográficas. 116(7). T703–T730.
4.
Prieto‐Pérez, Rocío, et al.. (2024). Ten-Year Persistence of Biologic Drugs in Psoriasis and Its Relationship with Pharmacogenetic Biomarkers. Biomedicines. 13(1). 5–5.
5.
6.
Sommer, Rachel, Ulrich Mrowietz, Kristian Gaarn du Jardin, et al.. (2023). Implementing well‐being in the management of psoriasis: An expert recommendation. Journal of the European Academy of Dermatology and Venereology. 38(2). 302–310. 7 indexed citations
7.
Daudén, E., et al.. (2023). First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab. SHILAP Revista de lepidopterología. 2(2). 369–372. 2 indexed citations
8.
Puig, L., et al.. (2023). Persistence and effectiveness of guselkumab treatment in patients with moderate‐to‐severe plaque psoriasis in a non‐interventional real‐world setting: The SPRING study. Journal of the European Academy of Dermatology and Venereology. 39(S1). 27–37. 3 indexed citations
9.
Frutos, F.J. Ortiz de, Ana M. Giménez‐Arnau, L. Puig, et al.. (2023). The DERMACLEAR study: Verification results of a natural language processing system in dermatology. SHILAP Revista de lepidopterología. 2(4). 775–785. 1 indexed citations
10.
Rivera, R., E. Daudén, J.M. Carrascosa, P. de la Cueva, & L. Puig. (2023). Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment. Dermatology and Therapy. 13(3). 673–688. 38 indexed citations
11.
Reolid, Alejandra, et al.. (2022). Cutaneous vascular calcification. Perieccrine calcification as a diagnostic key for calciphylaxis. Journal of Cutaneous Pathology. 49(8). 683–691.
12.
Fernandez, Anthony P., E. Daudén, Sascha Gerdes, et al.. (2022). Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2. Journal of the European Academy of Dermatology and Venereology. 36(10). 1774–1783. 15 indexed citations
13.
Duarte, Pablo, E. Daudén, Antonio Cuadrado, et al.. (2022). KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential. Medicinal Research Reviews. 43(1). 237–287. 134 indexed citations
14.
Llamas‐Velasco, Mar, Alejandra Reolid, Ancor Sanz‐García, et al.. (2020). Methylation in psoriasis. Does sex matter?. Journal of the European Academy of Dermatology and Venereology. 35(2). e161–e163. 3 indexed citations
15.
Nuño‐González, A., E. Daudén, F. Vanaclocha, et al.. (2016). Serie de casos de pacientes psoriásicas expuestas a terapia biológica durante el embarazo. Registro BIOBADADERM y revisión de la literatura. Actas Dermo-Sifiliográficas. 108(2). 168–170. 16 indexed citations
16.
Blome, Christine, Antonio Costanzo, E. Daudén, et al.. (2015). Patient-relevant needs and treatment goals in nail psoriasis. Quality of Life Research. 25(5). 1179–1188. 16 indexed citations
17.
Cabaleiro, Teresa, Manuel Román, Elena Gallo, et al.. (2013). Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients. European Journal of Dermatology. 23(5). 640–645. 19 indexed citations
18.
Daudén, E., et al.. (2011). Effectiveness and satisfaction with imiquimod for the treatment of superficial basal cell carcinoma in daily dermatological practice. Journal of the European Academy of Dermatology and Venereology. 25(11). 1304–1310. 14 indexed citations
19.
Katsambas, Andreas, Ketty Peris, Gino Antonio Vena, et al.. (2009). Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open‐label, Phase IIIb/IV Trial. PubMed. 2(4). 66–70. 11 indexed citations
20.
Daudén, E., et al.. (2005). Amiloidosis sistémicas. Actas Dermo-Sifiliográficas. 96(2). 69–82. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lotus Mallbris Breakdown of academic impact, for papers by Andrea L. Neimann Breakdown of academic impact, for papers by A. David Burden Breakdown of academic impact, for papers by C. Papavassilis Breakdown of academic impact, for papers by Reva Bhushan Breakdown of academic impact, for papers by Yves Poulin Breakdown of academic impact, for papers by Daniel B. Shin Breakdown of academic impact, for papers by Paolo Gisondi Breakdown of academic impact, for papers by Richard B. Warren Breakdown of academic impact, for papers by Joseph F. Merola
Rankless by CCL
2026